Agilent to Debut the Agilent Science and Technology Symposium 2012
News Feb 24, 2012
Agilent Technologies Inc. has announced that it will be hosting the Agilent Science and Technology Symposium 2012 in multiple phases.
ASTS will include an online symposium on February 29, followed by a mobile trade show, March 20 to June 12. The mobile trade show will visit 16 cities in North America and six in Latin America.
Visitors who attend the online symposium will be able to select from 10 e-seminars presented by Agilent and outside experts.
The e-seminars will cover a wide range of applications, from the latest in 2-D liquid chromatography through non-destructive testing of the world’s first composite airliner.
There will also be a virtual lounge where visitors can chat with colleagues and Agilent personnel.
The online event will feature more than 60 Agilent analytical tools from across the portfolio, including the latest in liquid and gas chromatography, mass spectrometry, atomic and molecular spectroscopy, consumables and software.
Visitors can learn about product benefits, obtain literature, watch videos, chat with sales representatives real-time, and request additional information.
For more information and to register, visit www.agilent.com/chem/ASTS.
For technology users who would like face-to-face interaction and direct inspection of the new products, Agilent is taking its mobile exhibition to 16 cities in North America and six in Latin America.
Each venue will feature morning presentations by Agilent experts, followed by lunch, product exhibits and afternoon presentations.
The program is designed to appeal to mainstream analytical interests from food testing to out-of-lab measurement.
Rapid Removal of Arsenic From Drinking Water...By Moss!News
A moss capable of removing arsenic from contaminated water has been discovered by researchers. And it happens quickly – in just one hour, the arsenic level is so low that the water is no longer harmful for people to drink.READ MORE
Stable Beta-Amyloid Dimers Identified in Alzheimer’s BrainsNews
A recent study exploited state-of-the-art mass spectrometry to provide the first direct evidence of beta-amyloid dimers in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers. Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.